Zhejiang Jolly Pharmaceutical Co Ltd (300181) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-23.58 Million ≈ $-3.45 Million USD) by net assets (CN¥3.18 Billion ≈ $465.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Zhejiang Jolly Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Zhejiang Jolly Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Zhejiang Jolly Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Jolly Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jolly Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Macmahon Holdings Ltd
AU:MAH
|
0.187x |
|
CT Real Estate Investment Trust
TO:CRT-UN
|
0.026x |
|
QCR Holdings Inc
NASDAQ:QCRH
|
0.004x |
|
Fujian Kuncai Material Tech
SHG:603826
|
0.061x |
|
IRSA Inversiones y Representaciones SA
BA:IRSA
|
0.017x |
|
Meridianlink Inc
NYSE:MLNK
|
0.049x |
|
American Superconductor Corporation
NASDAQ:AMSC
|
0.017x |
|
Norwegian Air Shuttle ASA
OL:NAS
|
1.090x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Zhejiang Jolly Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.24 Billion ≈ $474.31 Million |
CN¥411.80 Million ≈ $60.26 Million |
0.127x | +20.59% |
| 2024-12-31 | CN¥2.82 Billion ≈ $412.57 Million |
CN¥297.05 Million ≈ $43.47 Million |
0.105x | +1.31% |
| 2023-12-31 | CN¥2.77 Billion ≈ $405.92 Million |
CN¥288.46 Million ≈ $42.21 Million |
0.104x | -9.91% |
| 2022-12-31 | CN¥2.76 Billion ≈ $403.86 Million |
CN¥318.59 Million ≈ $46.62 Million |
0.115x | -9.08% |
| 2021-12-31 | CN¥1.98 Billion ≈ $290.21 Million |
CN¥251.80 Million ≈ $36.85 Million |
0.127x | -21.95% |
| 2020-12-31 | CN¥1.72 Billion ≈ $251.61 Million |
CN¥279.69 Million ≈ $40.93 Million |
0.163x | +77.59% |
| 2019-12-31 | CN¥1.41 Billion ≈ $206.00 Million |
CN¥128.94 Million ≈ $18.87 Million |
0.092x | +62.31% |
| 2018-12-31 | CN¥1.39 Billion ≈ $203.01 Million |
CN¥78.28 Million ≈ $11.46 Million |
0.056x | +1192.59% |
| 2017-12-31 | CN¥1.49 Billion ≈ $218.09 Million |
CN¥6.51 Million ≈ $952.09K |
0.004x | -88.98% |
| 2016-12-31 | CN¥1.47 Billion ≈ $215.38 Million |
CN¥58.30 Million ≈ $8.53 Million |
0.040x | -41.45% |
| 2015-12-31 | CN¥1.44 Billion ≈ $210.07 Million |
CN¥97.13 Million ≈ $14.21 Million |
0.068x | +330.67% |
| 2014-12-31 | CN¥871.76 Million ≈ $127.57 Million |
CN¥13.70 Million ≈ $2.00 Million |
0.016x | -58.87% |
| 2013-12-31 | CN¥772.52 Million ≈ $113.04 Million |
CN¥29.50 Million ≈ $4.32 Million |
0.038x | -11.63% |
| 2012-12-31 | CN¥705.92 Million ≈ $103.30 Million |
CN¥30.51 Million ≈ $4.46 Million |
0.043x | +116.47% |
| 2011-12-31 | CN¥683.92 Million ≈ $100.08 Million |
CN¥13.65 Million ≈ $2.00 Million |
0.020x | -93.61% |
| 2010-12-31 | CN¥207.17 Million ≈ $30.32 Million |
CN¥64.78 Million ≈ $9.48 Million |
0.313x | +18.04% |
| 2009-12-31 | CN¥165.70 Million ≈ $24.25 Million |
CN¥43.89 Million ≈ $6.42 Million |
0.265x | +26.77% |
| 2008-12-31 | CN¥149.11 Million ≈ $21.82 Million |
CN¥31.16 Million ≈ $4.56 Million |
0.209x | +88.11% |
| 2007-12-31 | CN¥144.47 Million ≈ $21.14 Million |
CN¥16.05 Million ≈ $2.35 Million |
0.111x | -- |
About Zhejiang Jolly Pharmaceutical Co Ltd
Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kid… Read more